Rifampicin-resistant tuberculosis
MONDO:0100479A form of drug-resistant tuberculosis that is resisant to rifampicin with or without resistance to other antitubercular medications.
Also known as: RR-TB, rifampicin-resistant TB
27 clinical trials for this condition and its sub-types, 20 tagged with Rifampicin-resistant tuberculosis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New hope for kids with Drug-Resistant TB: bedaquiline studied in children
Disease control CompletedThis study looked at how safe and tolerable the drug bedaquiline is for children and teens with rifampin-resistant tuberculosis, including those also living with HIV. Fifty-four participants received bedaquiline along with their regular TB treatment for 24 weeks. Researchers meas…
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New hope for kids with Drug-Resistant TB: pretomanid dose study completed
Disease control CompletedThis study tested a single dose of the drug pretomanid in 32 children with rifampicin-resistant tuberculosis (TB). The goal was to see how the drug moves through the body and whether it is safe when added to their regular TB treatment. The children were monitored for 48 hours aft…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Can newer tests match the gold standard for detecting Drug-Resistant TB?
Diagnosis CompletedThis study evaluates whether two newer line probe assays, the YD REBA MTB-MDR and Hain Genotype MTBDRplus V2, perform as well as the older Hain Genotype MTBDRplus V1 in detecting drug-resistant tuberculosis. Researchers will test stored, de-identified samples from adults with sym…
Sponsor: Foundation for Innovative New Diagnostics, Switzerland • Aim: Diagnosis
Last updated Sep 05, 2026 00:00 UTC